Synapse - Dean Bajorin

Results (663)

Muscle invasive bladder cancer (MIBC) demonstrates neoadjuvant cisplatin-based chemotherapy (NAC) related changes in molecular subtype and immune infiltration

Meeting Abstract

Funt, S. A.; Solovyov, A.; Faltas, B. M.; Iyer, G.; Boyd, M. E.; Cipolla, C. K.; Regazzi, A. M.; Teo, M. Y.; Lee, C. H.; Al-Ahmadie, H.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Keynote 057: Phase II trial of pembrolizumab (pembro) for patients (pts) with high-risk (HR) nonmuscle invasive bladder cancer (NMIBC) unresponsive to bacillus Calmette-Guérin (BCG)

Meeting Abstract

Balar, A. V.; Kulkarni, G. S.; Uchio, E. M.; Boormans, J.; Mourey, L.; Krieger, L. E. M.; Singer, E. A.; Bajorin, D. F.; Kamat, A. M.; Grivas, P.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Characterization of actionable genetic alterations to guide targeted therapy for metastatic urothelial carcinoma

Meeting Abstract

Almassi, N.; Pietzak, E. J.; Funt, S. A.; Schultz, N.; Dalbagni, G.; Bochner, B. H.; Al-Ahmadie, H.; Bajorin, D. F.; Rosenberg, J. E.; Iyer, G.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Oncologic therapy for solid tumors alters the risk of clonal hematopoiesis

Meeting Abstract

Bolton, K.; Ptashkin, R.; Braunstein, L.; Gao, T.; Devlin, S. M.; Kelly, D.; Coombs, C.; Patel, M.; Moarii, M.; Bernard, E.; more...
Cancer Research (2019)

Fulltext@MSK | Save

Impact of teratoma on the cumulative incidence of disease-related death in patients with advanced germ cell tumors

Journal Article

Funt, S. A.; Patil, S.; Feldman, D. R.; Motzer, R. J.; Bajorin, D. F.; Sheinfeld, J.; Tickoo, S. K.; Reuter, V. E.; Bosl, G. J.
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Updated interim analysis from Keynote-057: Pembrolizumab monotherapy for patients with high-risk non-muscle-invasive bladder cancer (NMIBC) unresponsive to bacillus Calmette-Guerin (BCG)

Meeting Abstract

Krieger, L.; de Wit, R.; Kulkarni, G. S.; Uchio, E. M.; Boormans, J. L.; Roumiguie, M.; Singer, E. A.; Bajorin, D. F.; Kamat, A. M.; Grivas, P.; more...
Asia-Pacific Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Impact of prognostic factors and risk groups on overall survival in patients treated with pembrolizumab vs investigator’s choice chemotherapy for advanced urothelial cancer: Post HOC analysis of Keynote-045

Meeting Abstract

Gurney, H.; Bellmunt, J.; de Wit, R.; Vaughn, D. J.; Fradet, Y.; Lee, J. L.; Fong, L.; Vogelzang, N. J.; Climent, M. A.; Petrylak, D. P.; more...
Asia-Pacific Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: Results of >2 years of follow-up

Journal Article

Fradet, Y.; Bellmunt, J.; Vaughn, D. J.; Lee, J. L.; Fong, L.; Vogelzang, N. J.; Climent, M. A.; Petrylak, D. P.; Choueiri, T. K.; Necchi, A.; more...
Annals of Oncology (2019)

Fulltext@MSK | Save

PD-L1 expression in urothelial carcinoma with predominant or pure variant histology: Concordance among 3 commonly used and commercially available antibodies

Journal Article

Reis, H.; Serrette, R.; Posada, J.; Lu, V.; Chen, Y. B.; Gopalan, A.; Fine, S. W.; Tickoo, S. K.; Sirintrapun, S. J.; Iyer, G.; more...
American Journal of Surgical Pathology (2019)

Fulltext@MSK | Save

Prognostic value of TERT alterations, mutational and copy number alterations burden in urothelial carcinoma

Journal Article

Isharwal, S.; Audenet, F.; Drill, E.; Pietzak, E. J.; Iyer, G.; Ostrovnaya, I.; Cha, E.; Donahue, T.; Arcila, M.; Jayakumaran, G.; more...
European Urology Focus (2019)

Fulltext@MSK | Save